The Recall Desk
LowFDA (Drugs)·D-574-2013·Announced 2013-06-12

Novartis Recalls Target Up & Up Athlete's Foot Cream for Labeling Issues

Novartis is recalling Target Up & Up athlete's foot cream because the lot and expiration dates on the tubes may not be legible.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the issue is limited to legibility of labeling information.

Plain-English summary

Novartis Consumer Health is recalling 99,660 tubes of Target Up & Up athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz). The recall was initiated because the lot and/or expiration date on the tube may not be legible in the affected lots.

The affected product is distributed nationwide, in Puerto Rico, and in Panama, with military distribution also made. The specific lot numbers and expiration dates involved are 10108716 (31-Mar-2013), 10111510 (30-Apr-2013), 10113801 (31-May-2013), 10113839 (30-Apr-2013), and 10115616 (31-Aug-2013).

Consumers should check their tubes for these specific lot numbers and expiration dates. If the product matches the recalled lots, consumers should stop using it and return it to the place of purchase for a refund or contact Novartis Consumer Health for further instructions.

The recalled product

Product
Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis,
Affected units
99,660

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot numbers and exp dates: 10108716 31-Mar-2013
  • 10111510 30-Apr-2013
  • 10113801 31-May-2013
  • 10113839 30-Apr-2013
  • 10115616 31-Aug-2013

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 5 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →